Amyris and DSM close US$50M strategic transaction on farnesene supply

The deal licenses DSM rights to assume the supply of farnesene to Givaudan

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

06 Jan 2021 --- Synthetic biotechnology company Amyris is launching its Biossance Clean Beauty skincare brand into the Greater China market via a partnership with SuperOrdinary... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

23 Dec 2020 --- The year saw COVID-19 tint every facet of nutrition, as the pandemic’s march caused industry disruptions and heightened interest in immunity. From... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Dec 2020 --- Functional ingredients that can mitigate stress, improve sleep and focus are high on consumers’ agendas as the COVID-19 pandemic presses on. Adaptogens such... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Dec 2020 --- Consumers’ intensifying pill fatigue coupled with concerns exacerbated by COVID-19 have created a demand for immunity NPD in innovative delivery formats.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

10 Dec 2020 --- With COVID-19 bringing overall health into focus, skin health and care are also coming to the fore. NutritionInsight speaks with cosmeceuticals experts, who discuss... Read More

trans